M. S. Steiner

565 total citations
20 papers, 437 citations indexed

About

M. S. Steiner is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, M. S. Steiner has authored 20 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in M. S. Steiner's work include Prostate Cancer Treatment and Research (8 papers), Bone health and treatments (7 papers) and Estrogen and related hormone effects (3 papers). M. S. Steiner is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Bone health and treatments (7 papers) and Estrogen and related hormone effects (3 papers). M. S. Steiner collaborates with scholars based in United States, Australia and Germany. M. S. Steiner's co-authors include Roger R. Dmochowski, K. Gary Barnette, David T. Price, S. Bruce Malkowicz, Paul Sieber, John B. Forrest, Franklin Chu, Matthew R. Smith, Penny Marschke and Robert P. Myers and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes and Endocrinology.

In The Last Decade

M. S. Steiner

20 papers receiving 409 citations

Peers

M. S. Steiner

PRM

UROLO

RHEUM

ONCOL

SURGE

Norman Heyden United States

Antonio Cardi Italy

J.L. Álvarez-Ossorio Spain

Pinhas Schächter Israel

Kanya Kaga Japan

C Loris Spain

Jung Hyun Shin South Korea

Christian Wallner Netherlands

Evis Daci Belgium

Norman Heyden United States

M. S. Steiner

103 ×0.4

PRM

31 ×0.2

UROLO

58 ×0.5

RHEUM

164 ×1.6

ONCOL

66 ×0.8

SURGE

Citations per year, relative to M. S. Steiner M. S. Steiner (= 1×) peers Norman Heyden

Countries citing papers authored by M. S. Steiner

Since Specialization

Citations

This map shows the geographic impact of M. S. Steiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. Steiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. Steiner more than expected).

Fields of papers citing papers by M. S. Steiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. S. Steiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. Steiner. The network helps show where M. S. Steiner may publish in the future.

Co-authorship network of co-authors of M. S. Steiner

This figure shows the co-authorship network connecting the top 25 collaborators of M. S. Steiner. A scholar is included among the top collaborators of M. S. Steiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. S. Steiner. M. S. Steiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Reichel, Martin, Eva M. Murauer, M. S. Steiner, Christoph Coch, & H Trübel. (2025). Philanthropic drug development: understanding its importance, mechanisms, and future prospects. Drug Discovery Today. 30(2). 104298–104298. 2 indexed citations

2.

Jones, Amanda, Christopher C. Coss, M. S. Steiner, & James T. Dalton. (2013). An overview on selective androgen receptor modulators: Focus on enobosarm. Drugs of the Future. 38(5). 309–309. 8 indexed citations

3.

Steiner, M. S., et al.. (2011). Effect of GTx-024, a selective androgen receptor modulator (SARM), on physical function in patients with non-small cell lung cancer (NSCLC) with cancer cachexia.. Journal of Clinical Oncology. 29(15_suppl). 9022–9022. 5 indexed citations

4.

Steiner, M. S., et al.. (2010). Effect of GTx-024, a selective androgen receptor modulator (SARM), on stair climb performance and quality of life (QOL) in patients with cancer cachexia.. Journal of Clinical Oncology. 28(15_suppl). 9147–9147. 3 indexed citations

5.

Veverka, Karen A., Bruce Malkowicz, Mitchell R. Smith, Ronald A. Morton, & M. S. Steiner. (2009). The effect of toremifene citrate on BMD in men on ADT: A phase III clinical trial. Journal of Clinical Oncology. 27(15_suppl). 5055–5055. 2 indexed citations

6.

Lin, Daniel W., Matthew R. Smith, Ronald A. Morton, & M. S. Steiner. (2009). Use of age and BMD to predict fracture risk in men on androgen deprivation therapy. Journal of Clinical Oncology. 27(15_suppl). 9517–9517. 2 indexed citations

7.

Smith, Matthew R., S. Bruce Malkowicz, Franklin Chu, et al.. (2007). Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase 3 Clinical Study. The Journal of Urology. 179(1). 152–155. 89 indexed citations

8.

Evans, William J., Mitchell R. Smith, John E. Morley, et al.. (2007). Ostarine increases lean body mass and improves physical performance in healthy elderly subjects: Implications for cancer cachexia patients. Journal of Clinical Oncology. 25(18_suppl). 9119–9119. 16 indexed citations

9.

Smith, Matthew Ryan, Fang‐I Chu, John B. Forrest, et al.. (2007). Effect of toremifene in lowering total cholesterol, LDL, and triglycerides and raising HDL in prostate cancer patients on androgen deprivation therapy. Journal of Clinical Oncology. 25(18_suppl). 5124–5124. 1 indexed citations

10.

Malkowicz, S. Bruce, Fang‐I Chu, John B. Forrest, et al.. (2007). Prevalence of osteoporosis and osteopenia during androgen deprivation (ADT) for prostate cancer: Baseline data from a large randomized controlled trial. Journal of Clinical Oncology. 25(18_suppl). 5116–5116. 4 indexed citations

11.

Smith, Matthew Ryan, Fang‐I Chu, John B. Forrest, et al.. (2006). Toremifene citrate increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology. 24(18_suppl). 4553–4553. 3 indexed citations

12.

Price, David T., B. Stein, Paul Sieber, et al.. (2005). Double-blind, placebo-controlled trial of toremifene for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia. Journal of Clinical Oncology. 23(16_suppl). 1003–1003. 5 indexed citations

13.

Steiner, M. S., Anthony Patterson, Ron Israeli, et al.. (2004). Toremifene citrate versus placebo for treatment of bone loss and other complications of androgen deprivation therapy in patients with prostate cancer. Journal of Clinical Oncology. 22(14_suppl). 4597–4597. 18 indexed citations

14.

Steiner, M. S., Anthony Patterson, Ron Israeli, et al.. (2004). Toremifene citrate versus placebo for treatment of bone loss and other complications of androgen deprivation therapy in patients with prostate cancer. Journal of Clinical Oncology. 22(14_suppl). 4597–4597. 5 indexed citations

15.

Walsh, Patrick C., Penny Marschke, William J. Catàlona, et al.. (2001). Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeons. Urology. 57(3). 491–494. 60 indexed citations

16.

Steiner, M. S.. (2000). Continence-preserving anatomic radical retropubic prostatectomy. Urology. 55(3). 427–435. 67 indexed citations

17.

Lynch, William J., et al.. (2000). Clinical Research Updates. World Journal of Urology. 18(0). S014–S015. 4 indexed citations

18.

Dmochowski, Roger R., et al.. (1998). Preservation of Putative Continence Nerves during Radical Retropubic Prostatectomy Leads to More Rapid Return of Urinary Continence. Urology. 51(6). 960–967. 104 indexed citations

19.

Solomon, S., et al.. (1987). Inhibitor of Calmodulin and cAMP Phosphodiesterase Activity in BB Rats. Diabetes. 36(2). 210–215. 20 indexed citations

20.

Solomon, S., et al.. (1986). Spontaneous Diabetic BB Rat: Studies of Cyclic Adenosine 3′,5′-Monophosphate Phosphodiesterase and Calmodulin*. Endocrinology. 119(4). 1839–1844. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact